

The Pharma Industry registered 9% growth in Q2 2023 compared to 15% in Q1 2023. Some of the key trends of Pharma Industry for Q2 2023 are as below –
Chronic therapies (10%) reflected better growth than Acute therapies (8%).
Cardiac, Chronic Respiratory and Neuro/CNS led in terms of growth amongst Chronic therapies. Anti-infectives, Pain Acute, Respiratory Acute and Gastro led in terms of growth amongst Acute therapies.
Indian companies (9%) grew faster than MNCs (6%).
VMN, Pain, Cardiac and Derma therapies saw maximum number of new launches in H1 Jun'23.
Download the presentation for more detailed insights.